Quantinno Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Quantinno Capital Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.65M	Buy	19,814 +11,502	+138%	+$3.39M	0.01%	1225
2026 Q1	$2.47M	Buy	8,312 +1,622	+24%	+$525K	﹤0.01%	1496
2025 Q4	$2.03M	Buy	6,690 +1,102	+20%	+$361K	﹤0.01%	1358
2025 Q3	$1.9M	Buy	5,588 +1,877	+51%	+$570K	0.01%	1248
2025 Q2	$898K	Buy	3,711 +1,143	+45%	+$280K	﹤0.01%	1351
2025 Q1	$699K	Buy	2,568 +1,221	+91%	+$285K	﹤0.01%	1270
2024 Q4	$249K	Buy	1,347 +33	+3%	+$6.74K	﹤0.01%	1457
2024 Q3	$295K	Buy	+1,314	New	+$236K	﹤0.01%	1271
2023 Q1	–	Sell	-998	Closed	-$220K	–	902
2022 Q4	$220K	Buy	+998	New	+$183K	0.02%	759

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Quantinno Capital Management's ONC Position: Q2 2026 in Review

Quantinno Capital Management increased its BeOne Medicines Ltd (ONC) stake by 138% in Q2 2026, buying an estimated $3.39M and bringing the position to 19,814 shares worth $5.65M. The position accounts for 0.01% of the portfolio, ranked #1225.

Quantinno Capital Management first reported a position in ONC in Q4 2022 and has held it in 9 quarters since. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Quantinno Capital Management held 19,814 shares of BeOne Medicines Ltd worth $5.65M as of Q2 2026.
Quantinno Capital Management bought 11,502 BeOne Medicines Ltd shares in Q2 2026, an estimated $3.39M.
BeOne Medicines Ltd made up 0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1225 holding.
Quantinno Capital Management first reported a position in BeOne Medicines Ltd in Q4 2022 and has held it in 9 quarters since.
283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.